MODIFICATION OF INTERPERSONAL PSYCHOTHERAPY WITH DEPRESSED ADOLESCENTS (IPT-A) - PHASE-I AND PHASE-II STUDIES

被引:69
|
作者
MUFSON, L [1 ]
MOREAU, D [1 ]
WEISSMAN, MM [1 ]
WICKRAMARATNE, P [1 ]
MARTIN, J [1 ]
SAMOILOV, A [1 ]
机构
[1] COLUMBIA UNIV COLL PHYS & SURG, CHILDRENS ANXIETY & DEPRESS CLIN, NEW YORK, NY 10032 USA
关键词
ADOLESCENCE; DEPRESSION; INTERPERSONAL PSYCHOTHERAPY;
D O I
10.1097/00004583-199406000-00011
中图分类号
B844 [发展心理学(人类心理学)];
学科分类号
040202 ;
摘要
Objective: To test the acceptability and efficacy of interpersonal psychotherapy for depressed adolescents (IPT-A). Method: in phase I, therapeutic methods were explored and refined in a small sample of depressed adolescents (n = 5). In phase II, 14 depressed adolescents entered a 12-week open clinical trial of IPT-A; after independent evaluation. Subjects were assessed using a semistructured diagnostic interview, self-report, and clinician-administered instruments, at six time points: evaluation week, and weeks 0, 2, 4, 8, and 12. Results: in phase I, treatment was modified to meet the needs of an adolescent population and was standardized in a treatment manual. The results of phase II indicated a significant decrease in adolescents' depressive symptomatology and symptoms of psychological and physical distress, as well as a significant improvement in functioning over the course of treatment. At termination, none of the subjects met DSM-III-R criteria for any depressive disorder. Conclusions: IPT-A appears to be a promising therapy for depressed adolescents. However, because of the limitations of the current study, a larger randomized controlled clinical trial is still needed to test its efficacy.
引用
收藏
页码:695 / 705
页数:11
相关论文
共 50 条
  • [21] PHARMACOLOGICAL EFFECTS OF PHASE-I AND PHASE-II METABOLITES OF TRIAMTERENE
    KNAUF, H
    MUTSCHLER, E
    VOLGER, KD
    WAIS, U
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1978, 28-2 (08): : 1417 - 1420
  • [22] COMBINED PHASE-I PHASE-II METHODS OF FEASIBLE DIRECTIONS
    POLAK, E
    TRAHAN, R
    MAYNE, DQ
    MATHEMATICAL PROGRAMMING, 1979, 17 (01) : 61 - 73
  • [23] DIURETIC ACTIVITY OF PHASE-I AND PHASE-II METABOLITES OF TRIAMTERENE
    ALBIEZ, G
    KNAUF, H
    MUTSCHLER, E
    VOLGER, KD
    WAIS, U
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1977, 297 : R36 - R36
  • [24] PHASE-I AND PRELIMINARY PHASE-II STUDIES ON ACLACINOMYCIN-A IN PATIENTS WITH ACUTE-LEUKEMIA
    SUZUKI, H
    KAWASHIMA, K
    YAMADA, K
    MINAMI, S
    KATO, Y
    TANIMOTO, M
    YAMADA, H
    ISOBE, K
    HAYASHI, K
    YAMAGUCHI, H
    TAKAMATSU, J
    WATANABE, E
    KODERA, Y
    SHIKU, H
    KAMIYA, T
    OHNO, R
    MORISHITA, H
    YOKOMAKU, S
    YOSHIDA, K
    OGURA, M
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1980, 10 (01) : 111 - 117
  • [25] KETAMINE ENHANCES PHASE-I AND PHASE-II NEUROMUSCULAR BLOCK OF SUCCINYLCHOLINE
    TSAI, SK
    LEE, CM
    TRAN, B
    CANADIAN JOURNAL OF ANAESTHESIA-JOURNAL CANADIEN D ANESTHESIE, 1989, 36 (02): : 120 - 123
  • [26] PHASE-I AND PHASE-II STUDY OF A NEW BLEOMYCIN ANALOG (PEPLEOMYCIN)
    MIURA, T
    KATAYAMA, K
    WADA, T
    RECENT RESULTS IN CANCER RESEARCH, 1981, 76 : 61 - 82
  • [27] PHASE-I - PRELIMINARY PHASE-II TRIAL OF IPROPLATIN, A CISPLATIN ANALOG
    PAOLOZZI, FP
    GAVER, R
    POIESZ, BJ
    LOUIE, A
    DIFINO, S
    COMIS, RL
    NEWMAN, N
    GINSBERG, S
    INVESTIGATIONAL NEW DRUGS, 1988, 6 (03) : 199 - 206
  • [28] PHASE-I PHASE-II INTERACTIONS IN NASCENT POLYOXYBENZOATE LAMELLAR CRYSTALS
    LIU, J
    GEIL, PH
    JOURNAL OF MACROMOLECULAR SCIENCE-PURE AND APPLIED CHEMISTRY, 1993, A30 : 183 - 190
  • [29] PHASE-I, PHASE-II TRIALS OF LENTINAN IN CANCER-PATIENT
    TAGUCHI, T
    INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1980, 2 (03): : 172 - 172
  • [30] PHASE-I AND PHASE-II METABOLITES OF BENZTROPINE IN RAT URINE AND BILE
    HE, H
    MCKAY, G
    MIDHA, KK
    XENOBIOTICA, 1995, 25 (08) : 857 - 872